{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:05:39Z","timestamp":1778594739980,"version":"3.51.4"},"reference-count":227,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.02059","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T04:39:46Z","timestamp":1599194386000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and \u201cNew Old Friends\u201d"],"prefix":"10.3389","volume":"11","author":[{"given":"Thomas-Oliver","family":"Kleen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia A.","family":"Galdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus G.","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2.","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1056\/nejmc2005696","article-title":"Death from Covid-19 of 23 health care workers in China.","volume":"382","author":"Zhan","year":"2020","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1186\/2046-2395-2-8","article-title":"Understanding how we age: insights into inflammaging.","volume":"2","author":"Baylis","year":"2013","journal-title":"Longev Healthspan."},{"key":"B4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak.","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"key":"B5","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1016\/S2214-109X(20)30264-3","article-title":"Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study.","volume":"8","author":"Clark","year":"2020","journal-title":"Lancet Global Health."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa160","article-title":"Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults\u2013United States, 2015\u20132017.","author":"Doyle","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B7","first-page":"3954","article-title":"Is innate immunity our best weapon for flattening the curve?","volume":"130","author":"Angka","year":"2020","journal-title":"J Clin Investig."},{"key":"B8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","article-title":"The COVID-19 vaccine development landscape.","volume":"19","author":"Le Thanh","year":"2020","journal-title":"Nat Rev Drug Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1016\/s0264-410x(03)00489-4","article-title":"How the SARS vaccine effort can learn from HIV-speeding towards the future, learning from the past.","volume":"21","author":"De Groot","year":"2003","journal-title":"Vaccine."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One."},{"key":"B11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.","volume":"5","year":"2020","journal-title":"Nat Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin.","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.17.20061440","article-title":"Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors.","author":"Braun","year":"2020","journal-title":"medRxiv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis.","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cll.2009.07.007","article-title":"Recently discovered human coronaviruses.","volume":"29","author":"Wevers","year":"2009","journal-title":"Clin Lab Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/s0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses.","volume":"66","author":"Masters","year":"2006","journal-title":"Adv Virus Res."},{"key":"B18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019: a model-based analysis.","volume":"20","author":"Verity","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-020-00180-2","article-title":"Can an effective SARS-CoV-2 vaccine be developed for the older population?","volume":"17","author":"Pawelec","year":"2020","journal-title":"Immun Ageing."},{"key":"B20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.coi.2016.11.003","article-title":"NK cells in host responses to viral infections.","volume":"44","author":"Lam","year":"2017","journal-title":"Curr Opin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I Interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice.","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients.","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01721-16","article-title":"The conserved coronavirus macrodomain promotes virulence and suppresses the innate immune response during severe acute respiratory syndrome coronavirus infection.","volume":"7","author":"Fehr","year":"2016","journal-title":"mBio."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/s2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation.","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/s0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression.","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm.","volume":"39","author":"Guo","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/CMR.00090-16","article-title":"The human immune response to respiratory syncytial virus infection.","volume":"30","author":"Russell","year":"2017","journal-title":"Clin Microbiol Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1128\/jvi.00527-07","article-title":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome.","volume":"81","author":"Cameron","year":"2007","journal-title":"J Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon.","volume":"2","author":"Totura","year":"2012","journal-title":"Curr Opin Virol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007390","article-title":"Toll-like receptor 4 in acute viral infection: too much of a good thing.","volume":"14","author":"Olejnik","year":"2018","journal-title":"PLoS Pathog."},{"key":"B31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.","volume":"133","author":"Imai","year":"2008","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/ehjcvp\/pvaa036","article-title":"Anticoagulation in COVID-19.","volume":"6","author":"Atallah","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19.","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0258-9","article-title":"DAMP-driven metabolic adaptation.","volume":"20","author":"Minton","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed.","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in COVID-19 patients.","author":"Manne","year":"2020","journal-title":"Blood."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00550","article-title":"A role for neutrophils in viral respiratory disease.","volume":"8","author":"Camp","year":"2017","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps.","volume":"217","author":"Barnes","year":"2020","journal-title":"J Exp Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mmbr.43.1.1-26.1979","article-title":"Role of macrophages in natural resistance to virus infections.","volume":"43","author":"Mogensen","year":"1979","journal-title":"Microbiol Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-4899-3748-3_9","article-title":"Macrophages and natural resistance to virus infections.","author":"Mogensen","year":"1988","journal-title":"Infection."},{"key":"B42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions.","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.4049\/jimmunol.1701135","article-title":"M1 means kill; M2 means heal.","volume":"199","author":"Ley","year":"2017","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines.","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages.","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.18632\/aging.101465","article-title":"Age-related M1\/M2 phenotype changes in circulating monocytes from healthy\/unhealthy individuals.","volume":"10","author":"Costantini","year":"2018","journal-title":"Aging."},{"key":"B47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1556\/eujmi-d-14-00035","article-title":"Ageing and the immune system: focus on macrophages.","volume":"5","author":"Linehan","year":"2015","journal-title":"Eur J Microbiol Immunol."},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13888-x","article-title":"Abnormal M1\/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD).","volume":"7","author":"Eapen","year":"2017","journal-title":"Sci Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.imbio.2017.11.001","article-title":"Macrophages: their role, activation and polarization in pulmonary diseases.","volume":"223","author":"Arora","year":"2018","journal-title":"Immunobiology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.4049\/jimmunol.1100889","article-title":"M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.","volume":"187","author":"Heusinkveld","year":"2011","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.virusres.2004.09.004","article-title":"SARS-coronavirus replication in human peripheral monocytes\/macrophages.","volume":"107","author":"Yilla","year":"2005","journal-title":"Virus Res."},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1079","article-title":"Human \u03b3\u03b4 T-cell receptor repertoire is shaped by influenza viruses, age and tissue compartmentalisation.","volume":"8","author":"Sant","year":"2019","journal-title":"Clin Transl Immunol."},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04076-0","article-title":"The human V\u03b42+ T-cell compartment comprises distinct innate-like V\u03b39+ and adaptive V\u03b39- subsets.","volume":"9","author":"Davey","year":"2018","journal-title":"Nat Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/502975","article-title":"Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells.","volume":"193","author":"Poccia","year":"2006","journal-title":"J Infect Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41423-020-0473-0","article-title":"More bricks in the wall against SARS-CoV-2 infection: involvement of \u03b39\u03b42 T cells.","volume":"17","author":"Rijkers","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1086\/378587","article-title":"Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome.","volume":"37","author":"Cui","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1086\/381535","article-title":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome.","volume":"189","author":"Li","year":"2004","journal-title":"J Infect Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/bmj.326.7403.1358","article-title":"Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis.","volume":"326","author":"Wong","year":"2003","journal-title":"BMJ."},{"key":"B59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s1386-6532(03)00195-1","article-title":"SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients.","volume":"28","author":"Li","year":"2003","journal-title":"J Clin Virol."},{"key":"B60","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa030634","article-title":"Identification of severe acute respiratory syndrome in Canada.","volume":"348","author":"Poutanen","year":"2003","journal-title":"N Engl J Med."},{"key":"B61","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJMoa030666","article-title":"A cluster of cases of severe acute respiratory syndrome in Hong Kong.","volume":"348","author":"Tsang","year":"2003","journal-title":"N Engl J Med."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19).","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China.","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.12.20034736","article-title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.","author":"Shi","year":"2020","journal-title":"medRxiv"},{"key":"B65","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.03.20030437","article-title":"Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients.","author":"Chen","year":"2020","journal-title":"medRxiv"},{"key":"B67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients.","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19.","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention.","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection.","volume":"154","author":"Fan","year":"2009","journal-title":"Arch Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.micinf.2006.05.008","article-title":"Human memory T cell responses to SARS-CoV E protein.","volume":"8","author":"Peng","year":"2006","journal-title":"Microbes Infect."},{"key":"B73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.virol.2006.03.036","article-title":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients.","volume":"351","author":"Peng","year":"2006","journal-title":"Virology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.","volume":"120","author":"Yang","year":"2006","journal-title":"Clin Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4049\/jimmunol.175.1.591","article-title":"Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals.","volume":"175","author":"Chen","year":"2005","journal-title":"J Immunol."},{"key":"B76","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2012.26","article-title":"Understanding the T cell immune response in SARS coronavirus infection.","volume":"1","author":"Janice Oh","year":"2012","journal-title":"Emerg Microbes Infect."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.26.115832","article-title":"Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals.","author":"Bert","year":"2020","journal-title":"bioRxiv"},{"key":"B78","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals.","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell."},{"key":"B79","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/cid\/ciy595","article-title":"Immune responses to middle east respiratory syndrome coronavirus during the acute and convalescent phases of human infection.","volume":"68","author":"Shin","year":"2019","journal-title":"Clin Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/s2213-2600(20)30076-x","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B81","article-title":"Clonally diverse CD38(+)HLA-DR(+)CD8(+) T cells persist during fatal H7N9 disease.","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun."},{"key":"B82","doi-asserted-by":"publisher","first-page":"11259","DOI":"10.1128\/jvi.01424-16","article-title":"Characterization of human CD8 T cell responses in dengue virus-infected patients from India.","volume":"90","author":"Chandele","year":"2016","journal-title":"J Virol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031535","article-title":"Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses.","volume":"7","author":"Fox","year":"2012","journal-title":"PLoS One."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation.","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B85","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00042560-199702010-00009","article-title":"CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.","volume":"14","author":"Mocroft","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1086\/380793","article-title":"CD38 expression in CD8+ T cells predicts virological failure in HIV type 1-infected children receiving antiretroviral therapy.","volume":"38","author":"Resino","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00042560-199710010-00003","article-title":"Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.","volume":"16","author":"Liu","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point.","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41590-019-0441-y","article-title":"PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1(+)CD38(hi) cells and anti-PD-1 resistance.","volume":"20","author":"Verma","year":"2019","journal-title":"Nat Immunol."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.28.20083089","article-title":"A possible role of immunopathogenesis in COVID-19 progression.","author":"Anft","year":"2020","journal-title":"medRxiv"},{"key":"B91","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/s0950268800048019","article-title":"The time course of the immune response to experimental coronavirus infection of man.","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol Infect."},{"key":"B92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.virol.2007.07.015","article-title":"Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.","volume":"368","author":"Libraty","year":"2007","journal-title":"Virology."},{"key":"B93","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study.","volume":"186","author":"Tang","year":"2011","journal-title":"J Immunol."},{"key":"B94","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3201\/eid2206.160010","article-title":"Antibody response and disease severity in healthcare worker MERS survivors.","volume":"22","author":"Alshukairi","year":"2016","journal-title":"Emerg Infect Dis."},{"key":"B95","first-page":"477","article-title":"Viral shedding and antibody response in 37 patients with middle east respiratory syndrome coronavirus infection.","volume":"62","author":"Corman","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3201\/eid2112.151421","article-title":"Kinetics of serologic responses to MERS coronavirus infection in humans, South Korea.","volume":"21","author":"Park","year":"2015","journal-title":"Emerg Infect Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/s1471-4906(01)01975-5","article-title":"Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways.","volume":"22","author":"Jankovic","year":"2001","journal-title":"Trends Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1056\/nejmoa1405858","article-title":"Transmission of MERS-coronavirus in household contacts.","volume":"371","author":"Drosten","year":"2014","journal-title":"N Engl J Med."},{"key":"B99","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(15)70090-3","article-title":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.","volume":"15","author":"Muller","year":"2015","journal-title":"Lancet Infect Dis."},{"key":"B100","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019.","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1128\/jvi.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J Virol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"11034","DOI":"10.1128\/jvi.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J Virol."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.20047365","article-title":"Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications.","author":"Wu","year":"2020","journal-title":"medRxiv"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.09.20148429","article-title":"Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection.","author":"Seow","year":"2020","journal-title":"medRxiv"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med."},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.21.20132449","article-title":"Intrafamilial exposure to SARS-CoV-2 induces cellular immune response without seroconversion.","author":"Gallais","year":"2020","journal-title":"medRxiv"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1128\/jvi.01394-09","article-title":"Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.","volume":"84","author":"Graham","year":"2010","journal-title":"J Virol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development.","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol."},{"key":"B109","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.","volume":"309","author":"Li","year":"2005","journal-title":"Science."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006546","article-title":"The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.","volume":"13","author":"Earnest","year":"2017","journal-title":"PLoS Pathog."},{"key":"B112","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.","volume":"495","author":"Raj","year":"2013","journal-title":"Nature."},{"key":"B113","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/d41586-020-01221-y","article-title":"The race for coronavirus vaccines: a graphical guide.","volume":"580","author":"Callaway","year":"2020","journal-title":"Nature."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants.","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"12201","DOI":"10.1128\/jvi.06048-11","article-title":"severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans.","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol."},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba8399","article-title":"A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques.","volume":"6","author":"van Doremalen","year":"2020","journal-title":"Sci Adv."},{"key":"B118","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/s1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.30.20142570","article-title":"Phase 1\/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: interim report.","author":"Mulligan","year":"2020","journal-title":"medRxiv"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.11.145920","article-title":"SARS-CoV-2 mRNA vaccine development enabled by prototype pathogen preparedness.","author":"Corbett","year":"2020","journal-title":"bioRxiv"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.13.093195","article-title":"ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques.","author":"van Doremalen","year":"2020","journal-title":"bioRxiv"},{"key":"B122","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192291","article-title":"Tissue-resident memory T cell reactivation by diverse antigen-presenting cells imparts distinct functional responses.","volume":"217","author":"Low","year":"2020","journal-title":"J Exp Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses.","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1292\/jvms.70.1315","article-title":"Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection.","volume":"70","author":"Takano","year":"2008","journal-title":"J Vet Med Sci."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-10-35","article-title":"Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells.","volume":"10","author":"Law","year":"2009","journal-title":"BMC Immunol."},{"key":"B126","first-page":"28","article-title":"Role of dendritic cells in SARS coronavirus infection.","author":"Lau","year":"2012","journal-title":"Hong Kong Med J."},{"key":"B127","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1172\/jci59777","article-title":"Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice.","volume":"121","author":"Zhao","year":"2011","journal-title":"J Clin Invest."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030005","article-title":"A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice.","volume":"3","author":"Roberts","year":"2007","journal-title":"PLoS Pathog."},{"key":"B129","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1128\/jvi.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice.","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol."},{"key":"B130","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.4049\/jimmunol.163.12.6448","article-title":"Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling.","volume":"163","author":"Brewer","year":"1999","journal-title":"J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.vaccine.2008.02.063","article-title":"Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.","volume":"26","author":"Bungener","year":"2008","journal-title":"Vaccine."},{"key":"B132","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19.","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/rmv.405","article-title":"Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.","volume":"13","author":"Takada","year":"2003","journal-title":"Rev Med Virol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/bf01310476","article-title":"A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.","volume":"120","author":"Hohdatsu","year":"1991","journal-title":"Arch Virol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.4049\/jimmunol.1203052","article-title":"Human FcgammaRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.","volume":"190","author":"Boonnak","year":"2013","journal-title":"J Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/s0952-7915(02)00409-0","article-title":"Fc receptors are major mediators of antibody based inflammation in autoimmunity.","volume":"14","author":"Hogarth","year":"2002","journal-title":"Curr Opin Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3201\/eid1111.040659","article-title":"Neutralizing antibody response and SARS severity.","volume":"11","author":"Ho","year":"2005","journal-title":"Emerg Infect Dis."},{"key":"B138","doi-asserted-by":"crossref","DOI":"10.1038\/s41423-020-0498-4","article-title":"RETRACTED ARTICLE: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.","author":"Wang","year":"2020","journal-title":"Cell Mol Immunol."},{"key":"B139","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight."},{"key":"B140","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.micinf.2020.02.006","article-title":"Is COVID-19 receiving ADE from other coronaviruses?","volume":"22","author":"Tetro","year":"2020","journal-title":"Microbes Infect."},{"key":"B141","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19.","volume":"368","author":"Moore","year":"2020","journal-title":"Science."},{"key":"B142","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome.","volume":"124","author":"Lee","year":"2014","journal-title":"Blood."},{"key":"B144","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia.","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"B145","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/s0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet."},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.22.20137273","article-title":"Effect of dexamethasone in hospitalized patients with COVID-19: preliminary report.","author":"Horby","year":"2020","journal-title":"medRxiv"},{"key":"B147","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.dsx.2020.06.054","article-title":"Role of corticosteroid in the management of COVID-19: a systemic review and a Clinician\u2019s perspective.","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr."},{"key":"B148","author":"Staines","year":"2020","journal-title":"Jury Still Out on IL-6 Drugs in COVID-19 Following Preliminary Trial Results."},{"key":"B149","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications.","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1146\/annurev.immunol.021908.132625","article-title":"Immunity to respiratory viruses.","volume":"27","author":"Kohlmeier","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/s2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ng.2744","article-title":"Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans.","volume":"45","author":"Comas","year":"2013","journal-title":"Nat Genet."},{"key":"B153","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/emph\/eot004","article-title":"Microbial \u2018Old Friends\u2019, immunoregulation and stress resilience.","volume":"2013","author":"Rook","year":"2013","journal-title":"Evol Med Public Health."},{"key":"B154","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nature05775","article-title":"Origins of major human infectious diseases.","volume":"447","author":"Wolfe","year":"2007","journal-title":"Nature."},{"key":"B155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijmyco.2012.01.001","article-title":"Mycobacteria and their world.","volume":"1","author":"Stanford","year":"2012","journal-title":"Int J Mycobacteriol."},{"key":"B156","doi-asserted-by":"crossref","DOI":"10.1186\/2051-1426-1-S1-P215","article-title":"Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer.","volume":"1","author":"Elia","year":"2013","journal-title":"J Immunother Cancer."},{"key":"B157","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00262-011-1121-4","article-title":"Mycobacteria activate gammadelta T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.","volume":"61","author":"Fowler","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"B158","article-title":"Defining the immunomodulatory effects of IMM-101: a promising, novel co-therapy for cancer.","author":"Galdon","year":"2019","journal-title":"Proceedings of the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, 25-28 September 2019"},{"key":"B159","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1046\/j.1365-2567.2003.01609.x","article-title":"Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production.","volume":"108","author":"Lagranderie","year":"2003","journal-title":"Immunology."},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.07.20053272","article-title":"Connecting BCG vaccination and COVID-19: additional data.","author":"Dayal","year":"2020","journal-title":"medRxiv"},{"key":"B161","author":"Hegarty","year":"2020","journal-title":"BCG Vaccination may be Protective Against Covid-19."},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.20042937","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study.","author":"Miller","year":"2020","journal-title":"medRxiv"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.08.20056051","article-title":"Exercising caution in correlating COVID-19 incidence and mortality rates with BCG vaccination policies due to variable rates of SARS CoV-2 testing.","author":"Hensel","year":"2020","journal-title":"medRxiv"},{"key":"B164","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coi.2018.09.001","article-title":"Induction of innate immune memory: the role of cellular metabolism.","volume":"56","author":"Dominguez-Andres","year":"2019","journal-title":"Curr Opin Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes.","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease.","volume":"352","author":"Netea","year":"2016","journal-title":"Science."},{"key":"B167","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/adc.2009.157537","article-title":"The non-specific effects of vaccines.","volume":"95","author":"Shann","year":"2010","journal-title":"Arch Dis Child."},{"key":"B168","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review.","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study.","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study.","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine."},{"key":"B172","first-page":"185","article-title":"The efficacy of bacillus calmette-guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly.","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones."},{"key":"B173","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"[Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations].","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen Igakkai Zasshi."},{"key":"B174","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity.","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B175","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1439-0450.2004.00763.x","article-title":"Taking advantage of the positive side-effects of smallpox vaccination.","volume":"51","author":"Mayr","year":"2004","journal-title":"J Vet Med B Infect Dis Vet Public Health."},{"key":"B177","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/infdis\/136.2.171","article-title":"Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guerin.","volume":"136","author":"Spencer","year":"1977","journal-title":"J Infect Dis."},{"key":"B178","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0166-3542(85)90025-7","article-title":"Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs.","volume":"5","author":"Ikeda","year":"1985","journal-title":"Antiviral Res."},{"key":"B179","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3181\/00379727-152-39327","article-title":"Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection.","volume":"152","author":"Starr","year":"1976","journal-title":"Proc Soc Exp Biol Med."},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107634","article-title":"\u03b2-Glucan induces protective trained immunity against Mycobacterium tuberculosis infection: a key role for IL-1.","volume":"31","author":"Moorlag","year":"2020","journal-title":"Cell Rep."},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02936","article-title":"Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations.","volume":"9","author":"Sanchez-Ramon","year":"2018","journal-title":"Front Immunol."},{"key":"B182","year":"2020","journal-title":"BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE):"},{"key":"B183","year":"2020","journal-title":"Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA):"},{"key":"B184","year":"2018","journal-title":"Immunization of Immunocompromised Persons: Canadian Immunization Guide."},{"key":"B185","first-page":"62","author":"Herr","year":"2009","journal-title":"BCG (LIVE), TICE<sup>\u00ae<\/sup> BCG [package insert].: Mucosal-local, USP Drug Information for the Healthcare Professional Oncolology Drug Information."},{"key":"B186","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/s1473-3099(02)00182-2","article-title":"BCG- different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis."},{"key":"B187","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/mt.2015.216","article-title":"Variable virulence and efficacy of BCG vaccine strains in mice and correlation with genome polymorphisms.","volume":"24","author":"Zhang","year":"2016","journal-title":"Mol Ther."},{"key":"B188","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1189\/jlb.0703313","article-title":"Dendritic cells derived from BCG-infected precursors induce Th2-like immune response.","volume":"76","author":"Martino","year":"2004","journal-title":"J Leukoc Biol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials.","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B190","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1128\/iai.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route.","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun."},{"key":"B191","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1128\/aac.27.2.203","article-title":"Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes.","volume":"27","author":"Douglas","year":"1985","journal-title":"Antimicrob Agents Chemother."},{"key":"B192","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1056\/nejmoa1714021","article-title":"Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination.","volume":"379","author":"Nemes","year":"2018","journal-title":"N Engl J Med."},{"key":"B193","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","article-title":"BCG immunotherapy of malignant melanoma: summary of a seven-year experience.","volume":"180","author":"Morton","year":"1974","journal-title":"Ann Surg."},{"key":"B194","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1099\/00221287-68-2-129","article-title":"Mycobacterium obuense, a rapidly growing scotochromogenic Mycobacterium capable of forming a black product from p-aminosalicylate and salicylate.","volume":"68","author":"Tsukamura","year":"1971","journal-title":"J Gen Microbiol."},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2016.342","article-title":"Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.","volume":"115","author":"Dalgleish","year":"2016","journal-title":"Br J Cancer."},{"key":"B196","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1602-8","article-title":"Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.","volume":"16","author":"Dalgleish","year":"2018","journal-title":"J Transl Med."},{"key":"B197","year":"2018","journal-title":"A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma:"},{"key":"B198","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/1753425917727838","article-title":"Immunomodulatory effects of heat-killed Mycobacterium obuense on human blood dendritic cells.","volume":"23","author":"Bazzi","year":"2017","journal-title":"Innate Immun."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.imbio.2015.07.015","article-title":"Analysis of the immunomodulatory properties of two heat-killed mycobacterial preparations in a human whole blood model.","volume":"220","author":"Bazzi","year":"2015","journal-title":"Immunobiology."},{"key":"B200","article-title":"The effects of combination treatment of IMM-101, a heat-killed whole cell preparation of Mycobacterium obuense (NCTC 13365) with checkpoint inhibitors in pre-clinical models.","author":"Crooks","year":"2016","journal-title":"Proceedings of the Annual Meeting of the SITC, 9-13 November 2016"},{"key":"B201","article-title":"The impact of Mycobacterium obuense (NCTC13365) on innate and adaptive immunity.","author":"Crooks","year":"2016","journal-title":"Proceedings of the Keystone Symposium Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies\u201d, 24-28 January 2016"},{"key":"B202","article-title":"The effect of IMM-101, a heat-killed whole cell preparation of Mycobacterium obuense (NCTC 13365) on dendritic cells and the adaptive immune response.","author":"Crooks","year":"2016","journal-title":"Proceedings of the Annual Congress of the BSI, 6-9 December 2016"},{"key":"B203","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.4049\/jimmunol.179.5.3057","article-title":"Central memory Vgamma9Vdelta2 T lymphocytes primed and expanded by bacillus Calmette-Guerin-infected dendritic cells kill mycobacterial-infected monocytes.","volume":"179","author":"Martino","year":"2007","journal-title":"J Immunol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.micinf.2004.12.009","article-title":"Antiviral reactivities of gammadelta T cells.","volume":"7","author":"Poccia","year":"2005","journal-title":"Microbes Infect."},{"key":"B205","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI200113584","article-title":"Antibacterial effect of human V gamma 2V delta 2 T cells in vivo.","volume":"108","author":"Wang","year":"2001","journal-title":"J Clin Invest."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1084\/jem.170.5.1521","article-title":"Molecular analysis of human gamma\/delta+ clones from thymus and peripheral blood.","volume":"170","author":"Casorati","year":"1989","journal-title":"J Exp Med."},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-017-0040-8","article-title":"Macrophages: damage control.","volume":"19","author":"Fehervari","year":"2018","journal-title":"Nat Immunol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.vetmic.2013.01.042","article-title":"Suppression of NK cells and regulatory T lymphocytes in cats naturally infected with feline infectious peritonitis virus.","volume":"164","author":"Vermeulen","year":"2013","journal-title":"Vet Microbiol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.4049\/jimmunol.178.11.6715","article-title":"Cutting edge: TLR2 directly triggers Th1 effector functions.","volume":"178","author":"Imanishi","year":"2007","journal-title":"J Immunol."},{"key":"B210","year":"2020","journal-title":"Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO):"},{"key":"B211","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1189\/jlb.3a0515-185r","article-title":"Mincle suppresses Toll-like receptor 4 activation.","volume":"100","author":"Greco","year":"2016","journal-title":"J Leukoc Biol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1189\/jlb.0103026","article-title":"TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.","volume":"74","author":"Heldwein","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.micinf.2020.04.005","article-title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement.","volume":"22","author":"Hotez","year":"2020","journal-title":"Microbes Infect."},{"key":"B214","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1002\/eji.201545591","article-title":"Fonsecaea pedrosoi-induced Th17-cell differentiation in mice is fostered by Dectin-2 and suppressed by Mincle recognition.","volume":"45","author":"Wuthrich","year":"2015","journal-title":"Eur J Immunol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3181\/00379727-59-15006p","article-title":"The cellular transfer of cutaneous hypersensitivity to tuberculin.","volume":"59","author":"Chase","year":"1945","journal-title":"Exp Biol Med."},{"key":"B216","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3181\/00379727-49-13670","article-title":"Experiments on transfer of cutaneous sensitivity to simple compounds.","volume":"49","author":"Landsteiner","year":"1942","journal-title":"Exp Biol Med."},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01662","article-title":"Sensing lipids with mincle: structure and function.","volume":"8","author":"Williams","year":"2017","journal-title":"Front Immunol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/cas.12824","article-title":"Adjuvant for vaccine immunotherapy of cancer\u2013focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity.","volume":"106","author":"Seya","year":"2015","journal-title":"Cancer Sci."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med."},{"key":"B220","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.4049\/jimmunol.1302850","article-title":"Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.","volume":"192","author":"Shen","year":"2014","journal-title":"J Immunol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1128\/jvi.00983-14","article-title":"Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.","volume":"88","author":"Iwata-Yoshikawa","year":"2014","journal-title":"J Virol."},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020053","article-title":"Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.","volume":"2","author":"Le Goffic","year":"2006","journal-title":"PLoS Pathog."},{"key":"B223","article-title":"TLR4 signaling induces TLR3 up-regulation in alveolar macrophages during acute lung injury.","volume":"7","author":"Ding","year":"2017","journal-title":"Sci Rep."},{"key":"B224","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10753-017-0720-4","article-title":"Association of respiratory syncytial virus Toll-like receptor 3-mediated immune response with COPD exacerbation frequency.","volume":"41","author":"Liu","year":"2018","journal-title":"Inflammation."},{"key":"B225","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.molimm.2019.06.006","article-title":"TLR1\/TLR2 signaling blocks the suppression of monocytic myeloid-derived suppressor cell by promoting its differentiation into M1-type macrophage.","volume":"112","author":"Deng","year":"2019","journal-title":"Mol Immunol."},{"key":"B226","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-017-1447-1","article-title":"TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1\/M2 phenotype.","volume":"19","author":"Quero","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"B227","article-title":"Novel immunomodulators and their combinations require a broad, adaptive clinical biomarker strategy.","author":"Kleen","year":"2020","journal-title":"Proceedings of the CYTO Virtual 2020 Conference, 4-5 August 2020"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T21:15:52Z","timestamp":1696626952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.02059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":227,"alternative-id":["10.3389\/fimmu.2020.02059"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.02059","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"article-number":"2059"}}